532154 — Johnson Pharmacare Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹330.00m
- IN₹340.74m
- 41
- 53
- 11
- 22
Annual cashflow statement for Johnson Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.012 | 0.967 | -13.3 | -1.96 | -5.84 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0 | 0 | 0 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.1 | 48 | 5,005,700 | 1.51 | -13.3 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.08 | 49 | 5,005,687 | -0.454 | -19.1 |
| Other Investing Cash Flow Items | 0 | -50.1 | -5,005,700 | 0 | 32.7 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -50.1 | -5,005,700 | 0 | 32.7 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.622 | -0.83 | 13 | 0.45 | -13.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.462 | -1.92 | -0.388 | -0.004 | 0.129 |